Cancer-Specific miRNAs Extracted from Tissue-Exudative Extracellular Vesicles in Ovarian Clear Cell Carcinoma
article
OA: gold
CC0
AI-generated summary
This study identified six extracellular vesicle miRNAs significantly decreased after surgery in ovarian clear cell carcinoma patients, highlighting their potential as biomarkers for early detection of this cancer arising from endometriotic cysts.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Ovarian clear cell carcinomas (OCCs) arise from endometriotic cysts that many women develop. Biomarkers for early OCC detection need to be identified. Extracellular vesicles have attracted attention as biomarker carriers. This study aims to identify cancer-specific miRNAs as novel OCC biomarkers using tissue-exudative extracellular vesicles (Te-EVs). Te-EVs were collected from four patients with OCC on one side and a normal ovary on the other side. Microarray analysis was performed to identify cancer-specific miRNAs in Te-EVs. Serum samples obtained before and after surgery from patients with OCC and atypical endometrial hyperplasia (AEH) (controls) were compared using real-time PCR to examine changes in the detected EV miRNA levels. Thirty-seven miRNAs were >2-fold upregulated on the OCC side compared with the normal ovarian side. We selected 17 miRNAs and created specific primers for 12 of these miRNAs. The levels of six EV miRNAs were significantly decreased in postoperative OCC serum compared to those in preoperative OCC serum. In contrast, no significant change was observed between the pre and postoperative values in the control group. We identified OCC tissue-specific miRNAs in the EVs secreted by OCC tissues. These EV miRNAs have potential for use as biomarkers for the early diagnosis and detection of OCC.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
References (39)
- <i>ARID1A</i> Mutations in Endometriosis-Associated Ovarian Carcinomas via openalex
- W1964314383 via openalex
- W1983085353 via openalex
- W1991581123 via openalex
- W2014626044 via openalex
- W2035844407 via openalex
- W2100339207 via openalex
- W2121354606 via openalex
- W2155131748 via openalex
- W2164890175 via openalex
- W2319374670 via openalex
- W2429612451 via openalex
- W2474544325 via openalex
- W2512860960 via openalex
- W2513687207 via openalex
- W2516517104 via openalex
- W2621106537 via openalex
- W2623472766 via openalex
- W2624026115 via openalex
- W2793118287 via openalex
- W2886216071 via openalex
- W2900304024 via openalex
- W2914330320 via openalex
- W2994977341 via openalex
- W3036135178 via openalex
- W3102224823 via openalex
- W3111315732 via openalex
- W3133811159 via openalex
- W3189888744 via openalex
- W4234160457 via openalex
- W4253734173 via openalex
- W4281667999 via openalex
- W4283269910 via openalex
- W4295027448 via openalex
- W4295561063 via openalex
- W4297384873 via openalex
- W4297779995 via openalex
- W1918214981 via openalex
- W4308332190 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK